Effect of intravenous vitamin c in decreasing ferritin level in patients with ESRD under dialysis
Phase 3
- Conditions
- Chronic kidney disease (CKD).Anemia in chronic kidney diseaseD63.1
- Registration Number
- IRCT20191112045426N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Patients undergoing hemodialysis with iron deficiency anemia with Hb <11 g / dl and serum ferritin level (> 500 ng / ml) and transferrin saturation (TSAT = 20%)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Age. Timepoint: before intervention. Method of measurement: Form.;Gender. Timepoint: before intervention. Method of measurement: Form.;Marital status. Timepoint: before intervention. Method of measurement: Form.;Serum ferritin level. Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;Hemoglobin. Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;TIBC(Total Iron binding capacity ). Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;Transferrin saturation. Timepoint: before intervention and after three months. Method of measurement: Paraclinic.;Intervention group. Timepoint: before intervention and after three months. Method of measurement: software.
- Secondary Outcome Measures
Name Time Method